Sagimet Biosciences’ Post

iTestis, led by Ass/Prof Ben Tran in collaboration with WEHI, is revolutionising clinical data collection for GCT patients in Australia. It provides a comprehensive solution to the challenges of data collection and analysis in the treatment of germ cell tumours. By collecting high-quality clinical data and linking it with biological specimens, iTestis describes the current practice patterns of Australian clinicians and engages in retrospective research projects and translational studies. It also serves as a platform for registry-based clinical trials. Powered by BioGrid's secure platform, iTestis is setting new standards in GCT patient care. Read more - https://loom.ly/Wy_eCJA

    Will you be at IBMS CONGRESS? Let me know! It’s not long until IBMS Congress 2023 and I would love to catch up with you!    You'll find me on Velsera’s booth, so come and say hi and learn about all our offerings, including smart sample-to-result software that can automate your lab’s workflow. You will find us in the Foyer, next to Hall 1, Stand F1.    See how FastFinder AI software can revolutionise the way in which diagnostic labs work & the many benefits of incorporating this unique, customisable software to your workflows.    Some of the benefits of FastFinder include: *Reduce errors by removing manual steps. *Improve accuracy and consistency in reporting results though automated data analysis.  *Save time and costs, no secondary review of results needed, only look at the ones that matter. Want to learn more? You know where to find me! Stand F1 in the foyer.

📌 HORIZON | IMMUTOL 1st Progress Meeting ↪️ Last week, Immutol partners gathered in Barcelona for the 1st Annual Meeting of the Immutol project (6-7 June) to celebrate the progress of this European Union funded project. ASPHALION, in charge of the regulatory activities, presented a summary of the regulatory road map (deliverable 6.1) within WP6. Preliminary results from partners were presented, and a roundtable on the hot topic of target patient selection guided the project's progression through the 2nd year. ↪️ Immutol’s objective is to pave the way for new #tolerogenic #cellbased therapies to cure/reverse several #autoimmune conditions, developing a more potent and durable #treatment for autoimmune diseases with an unmet medical need, particularly #MultipleSclerosis. 🔗 Check out our website to read the full article: https://bit.ly/3RrmlXH #EU #EuropeanUnionfundedProject #HORIZON #CellBasedTherapy #AutoimmuneDisease #MultipleSclerosis #ChronicDisease #RA #RegulatoryAffaird #MeetTheExpert #WeAreAsphalion #WeCare #KnowledgeFromExperience Ester Cantó Puig Montse de Castellarnau Serra, PhD

Something new is coming to PVRI...Introducing our webinar series, PVRI 2023/24 Digital, launching November 2023. The series follows the success of our 2021/22 series and has been developed by Dr Patricia Thistlethwaite, MD, PhD, University of California San Diego. Upcoming webinars: 🌐 PAH risk calculators – state of the art assessment 🌐 Controversies in CTEPH: pro-con debate 🌐 Clinical trials for PAH: what are we learning? 🌐 Enhancing drug development for paediatric PH: an integrative perspective 🌐 Ion channels: pathogenic role & therapeutic intervention in PAH 🌐 Single cell transcriptional profiling in lung health and PAH Learn more about the scientific programme, book onto upcoming webinars or watch recordings of missed webinars here: https://pvri.link/digital #PulmonaryHypertension

Can Understanding HO-1 in BACH1 Knockout Mice Help Treat Sepsis Better? Raghavan Pillai Raju, Medical College of Georgia at Augusta University, USA, will present a short oral contribution during #RedoxMedicine2024 elaborating on this topic. Dr. Raju will discuss  the regulation of HO-1 in BACH1 knockout mice following sepsis. He will provide new insights into the regulatory mechanisms of HO-1 in response to sepsis, potentially informing new therapeutic strategies. Join us on June 27-28, 2024 at Fondation Biermans-Lapôtre, Paris, to learn more! 🔗 Selected Short Orals: https://lnkd.in/gypa9uFD. 🌐 More information: https://lnkd.in/dkNzFQZU. #RedoxMedicieSociety #RedoxMedicine2024 #biomarkers #redoxbiology #redox #antioxidants #innovation #oxidativestress #RedoxResearch

📢 Join SynapCell at the EILAT XVII Conference in Madrid, Spain, from May 5 to 8, 2024! Corinne Roucard, CEO of SynapCell, will be presenting a poster entitled "Differential Profile of Anti-seizure Medications in the Rat Amygdala-Kindling Model", exploring how the translational aspects of the kindled amygdala in the rat are enabling the identification of new compounds with improved tolerance and efficacy on focal and secondarily generalized seizures. The combination of this model and a cross-over design empower our decision-enabling testing platform to identify novel compounds for the prevention, treatment, and modification of #epilepsy, wherein pharmacoresistant focal seizures constitute the greatest challenge for treatment. 👉For more information and set a meeting, please contact Corinne Roucard. 👉Read the abstract: https://lnkd.in/eQh2Mejp #eilatconference #epilepsy #EEG

🌟 Take a glimpse into the groundbreaking work happening at IPATH, a hub of innovation and excellence within the field of medicine. 💊🔬 Our team is dedicated to pioneering research, driving advancements, and pushing the boundaries of what's possible in the fight against #antimicrobialresistance. 🦠💪 Curious to learn more about our cutting-edge projects, collaborations, and the transformative impact of phage therapies? 💡 Dive into the details on our website. 🚀 Here's why you should explore it!: 1️⃣ In-Depth Insights: Uncover the science behind phage applications and therapeutics with detailed information on our ongoing research initiatives. 2️⃣ Meet the Experts: Get to know the brilliant minds behind the groundbreaking discoveries, their expertise, and the passion driving our mission. 3️⃣ Impactful Stories: Discover real-life stories showcasing the positive impact of phage therapies on patients' lives. Join us on this journey of discovery, innovation, and healing! 🌍💙 Your support and interest make a difference. Feel free to like, share, and spread the word! Together, let's make strides in transforming healthcare and shaping a healthier future. #PhageTherapeutics #InnovationInMedicine #HealthcareRevolution #ResearchExcellence

Were you unable to connect with us during ISPOR Europe in November? Discover more about one of the posters showcased by Evidinno by following the link below. Findings highlight a significant social transformation in clinical drug development, emphasizing the role of patients as active collaborators, and suggest that personalized clinical trials hold great promise for enhancing patient recruitment and retention in clinical research. https://lnkd.in/ggVT-t59

For more information on this Oral Abstract where GOG-3059 will be presented during the 2024 ASCO Annual Meeting, go to https://ow.ly/4QV050S0FhW or click in bio. #clinicaltrials #GOGF #GOGPartners #GynecologicOncology #ASCO24